BioSpace News Archive

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of a post-hoc analysis from the N-MOmentum Phase 3 pivotal trial of UPLIZNA, showing that the medicine was safe and effective in NMOSD patients who were treated with UPLIZNA after having only one attack.

The Alliance for Regenerative Medicine, the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies, today released its 2021 Annual Report, showcasing a year of significant advances and forecasting continued growth ahead.

Stemedica Cell Technologies, Inc. announced that it has appointed Darius Anderson, a veteran business executive and one of the state of California’s most respected entrepreneurs and political strategists, to its Board of Directors.

Albany NY, United States: Platelet are blood cells, which make up small volume of the blood and prevents bleeding.

Cardiac arrhythmia relates to irregular rate or rhythm of heartbeat, and while most of these conditions are fairly harmless, certain cases can be utterly serious and even lead to death as the lack of blood flow can severely damage the heart, brain, and other organs.

Albany NY, United States: Renal cell carcinoma, also known as adenocarcinoma, refers to the cancer of kidneys in which malignant cells are found in the renal tubules.

Albany NY, United States: The prime objective of vaccination is to generate a strong immune response to the administered antigen so that it can deliver strong protection against infection.

Albany NY, United States: Peptides are mainly made up of amino acid chains which are linked with each other with the peptide bond.

Turin, Italy,312022 – Kither Biotech, a biopharmaceutical company developing novel therapies for rare respiratory diseases, announces the publication of a study in Science Translational Medicine describing the mechanism of action of its lead asset, KIT2014, and proof-of-concept data for its use for the treatment of chronic obstructive airway diseases.

RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported its results for the full-year ended December 31, 2021 and provided a corporate update.